ADVERTISEMENT

404

Not Found

Is this what you were looking for?

tag cancer biochemistry neuroscience neurodegeneration

Raising the Bar for Biomarkers and Early Diagnostics in Neurodegenerative Disease
Raising the Bar for Biomarkers and Early Diagnostics in Neurodegenerative Disease
Fortis Life Sciences | Jun 20, 2022 | 3 min read
Identifying novel biomarkers of Parkinson’s disease enables early diagnosis and treatment monitoring.
Photo of Ankara Jain in his lab
Ankur Jain Explores RNA Aggregations in Neurodegenerative Disease
Hannah Thomasy, PhD | Oct 3, 2022 | 3 min read
The MIT biologist studies how RNA molecules self-assemble and the role these accumulations may play in diseases such as ALS and Huntington’s.
Bonn to battle Neurodegeneration
Annette Tuffs | Jan 12, 2009 | 6 min read
Bonn to battle Neurodegeneration A new research center to combat dementia joins a network of neuroscience institutes along the Rhine axis. By Annette Tuffs The view from Venusberg hill, the site of the new German Helmholtz Center for Neurodegenerative Diseases at University Hospital. It is the disease of forgetting—and was for a long time a forgotten disease. Dementia, the seemingly inevitable loss of memory and personality asso
Waste-Management Consultant
Megan Scudellari | Nov 1, 2013 | 9 min read
By audaciously pursuing an abandoned area of research, Ana María Cuervo discovered how cells selectively break down their waste, and revealed the health consequences when that process malfunctions.
Contributors
Diana Kwon | May 1, 2017 | 4 min read
Meet some of the people featured in the May 2017 issue of The Scientist.
Top 10 Innovations 2021
2021 Top 10 Innovations
The Scientist | Dec 1, 2021 | 10+ min read
The COVID-19 pandemic is still with us. Biomedical innovation has rallied to address that pressing concern while continuing to tackle broader research challenges.
The Regenerator
Anna Azvolinsky | Dec 1, 2015 | 9 min read
In his search for effective therapies for Parkinson’s disease, Lorenz Studer is uncovering pluripotency switches and clues to what makes cells age.
Mapping Brain Proteins
Devika G. Bansal | Feb 1, 2018 | 7 min read
Researchers are using souped-up mass spectrometry to localize proteins within brain cells.
2020 Top 10 Innovations
The Scientist | Dec 1, 2020 | 10+ min read
From a rapid molecular test for COVID-19 to tools that can characterize the antibodies produced in the plasma of patients recovering from the disease, this year’s winners reflect the research community’s shared focus in a challenging year.
Ubiquitin-Mediated Proteolytic System Plays Diverse Roles in Human Disease
Douglas Steinberg | Jul 19, 1998 | 9 min read
A pharmaceutical milestone seems to have been reached last month when a National Cancer Institute panel approved an anti-tumor drug called PS-341 for government-financed clinical trials. PS-341 is the first agent targeting the ubiquitin-mediated proteolytic system to be headed for human testing, according to ProScript Inc., the small firm in Cambridge, Mass., that developed the drug. Clinical trials at NCI and several medical centers could begin later this summer if the Food and Drug Administra

Run a Search

ADVERTISEMENT